CompletedNot Applicable

Observational Study of Oralair® in Children 5-9 Years With Grass-pollen-induced Allergic Rhinitis With/Without Conjunctivitis

Germany307 participantsStarted 2014-12

Plain-language summary

Safety and tolerability of ORALAIR in children 5 to 9 years of age during the first 30 days of treatment.

Who can participate

Age range5 Years – 9 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: Allergen immunotherapy naive male or female outpatients aged 5 to 9 years (inclusive) prescribed ORALAIR. Exclusion Criteria: Patients already participating in a clinical trial.

What they're measuring

All adverse events that started on or after the day the first dose of Oralair

Timeframe: During 30 days after the date of the first dose

Trial details

NCT IDNCT02295969

SponsorStallergenes Greer

Sponsor typeINDUSTRY

Study typeOBSERVATIONAL

Primary completion2017-07-03

View on ClinicalTrials.gov More Allergy trials